Cigna's prior authorization for GLP-1 weight loss medications typically requires documentation that the patient has a BMI of 30 or greater (or 27 or greater with qualifying comorbidity), has completed at least three months of a structured lifestyle modification program, and has not responded adequately to lifestyle changes alone
Joseph Schacht, PhD, associate professor of psychiatry, talked about GLP-1s psychological effects and potential as an addiction treatment
Whether your goal is to lose weight, get stronger, or simply feel better in your body, we can build a plan that supports all of the above
PIONEER 6 was the only trial that evaluated mortality or diabetes-related morbidity as efficacy outcomes
Tirzepatide targets both GLP-1 and GIP receptors, working to regulate blood sugar, decrease appetite, and improve fat metabolism
PMID 18042717